Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP807268.RAdPlM2y5NJCSfVYKLs2E5iGAF9HP1wKFrko3GDRt1-Lc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807268.RAdPlM2y5NJCSfVYKLs2E5iGAF9HP1wKFrko3GDRt1-Lc130_assertion type Assertion NP807268.RAdPlM2y5NJCSfVYKLs2E5iGAF9HP1wKFrko3GDRt1-Lc130_head.
- NP807268.RAdPlM2y5NJCSfVYKLs2E5iGAF9HP1wKFrko3GDRt1-Lc130_assertion description "[A cohort of PI3K/AKT/mTOR inhibitors was more efficacious in breast cancers compared with other tumor types, whereas IGF-IR inhibitors more selectively inhibited growth in colon cancer lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807268.RAdPlM2y5NJCSfVYKLs2E5iGAF9HP1wKFrko3GDRt1-Lc130_provenance.
- NP807268.RAdPlM2y5NJCSfVYKLs2E5iGAF9HP1wKFrko3GDRt1-Lc130_assertion evidence source_evidence_literature NP807268.RAdPlM2y5NJCSfVYKLs2E5iGAF9HP1wKFrko3GDRt1-Lc130_provenance.
- NP807268.RAdPlM2y5NJCSfVYKLs2E5iGAF9HP1wKFrko3GDRt1-Lc130_assertion SIO_000772 20406975 NP807268.RAdPlM2y5NJCSfVYKLs2E5iGAF9HP1wKFrko3GDRt1-Lc130_provenance.
- NP807268.RAdPlM2y5NJCSfVYKLs2E5iGAF9HP1wKFrko3GDRt1-Lc130_assertion wasDerivedFrom befree-2016 NP807268.RAdPlM2y5NJCSfVYKLs2E5iGAF9HP1wKFrko3GDRt1-Lc130_provenance.
- NP807268.RAdPlM2y5NJCSfVYKLs2E5iGAF9HP1wKFrko3GDRt1-Lc130_assertion wasGeneratedBy ECO_0000203 NP807268.RAdPlM2y5NJCSfVYKLs2E5iGAF9HP1wKFrko3GDRt1-Lc130_provenance.